Humira
Need help?
Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.
What Is Humira?
Humira is a brand name for the medication adalimumab. It is an FDA-approved drug that is commonly prescribed to treat various inflammatory conditions. Adalimumab belongs to a class of drugs called tumor necrosis factor (TNF) inhibitors. Patients with rheumatoid arthritis, Crohn's disease, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, hidradenitis suppurativa, and plaque psoriasis may be prescribed Humira to help alleviate their symptoms. The medication works by blocking TNF, a protein in the body that causes inflammation. By inhibiting TNF, Humira helps to reduce pain, swelling, and stiffness in the joints, as well as alleviate symptoms associated with these inflammatory conditions. It is usually administered through injections under the skin, and the dosage and frequency of administration may vary depending on the specific condition being treated. It's important to note that Humira may have certain side effects, including injection site reactions, flu-like symptoms, gastrointestinal issues, and an increased risk of infections. Therefore, it should only be used under the supervision of a healthcare professional, who will closely monitor the patient's response to the medication and make any necessary adjustments to the treatment plan.
How to use Humira?
Humira, also known by its generic name adalimumab, is a medication that is administered by injection. It is prescribed to treat various inflammatory conditions, including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and other related conditions. Here are the general steps for using Humira: 1. Administration: Humira comes in a pre-filled syringe or prefilled pen that contains the medication. Before using, check the expiration date and the appearance of the medication. If it appears discolored or contains particles, do not use it. 2. Preparation: Wash your hands thoroughly. Choose an injection site, such as the thigh or abdomen, and clean the area with an alcohol swab. Let the area dry completely before proceeding. 3. Injection: Hold the syringe or pen firmly and remove the cap. Some pen devices may require the removal of an outer needle cap. Do not touch the needle or allow it to come into contact with any surface. 4. Injection technique: For subcutaneous injections, hold the syringe or pen at a 45-degree angle and insert the needle into the skin according to your healthcare provider's instructions. Slowly push the plunger to inject the medication. If you are unsure about the injection technique, consult your healthcare provider or pharmacist. 5. Disposal: Safely dispose of the used syringe or pen according to your local regulations. Do not recap the needle or reuse any part of the device. Always follow your healthcare provider's instructions and the medication's label when using Humira. If you have any questions or concerns about its use, discuss them with your healthcare provider or pharmacist. They can provide you with specific guidance tailored to your condition and needs.
Humira, also known by its generic name adalimumab, is a medication used to treat various inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and plaque psoriasis. While it can be effective in managing these conditions, it’s important to be aware of certain warnings associated with its use. Here are a few: 1. Serious infections: Humira can lower the immune system's ability to fight infections, making you more susceptible to potentially severe infections. It’s essential to report any signs of infection, such as fever, cough, or persistent illness, to your healthcare provider promptly. 2. Tuberculosis (TB): Humira can increase the risk of developing active TB or reactivating latent TB. Before starting Humira, your doctor will likely test you for TB and may monitor you for symptoms such as cough, weight loss, or fever during treatment. 3. Cancer risk: There have been rare cases of lymphoma and other cancers reported in patients using Humira or similar medications. While the overall risk is low, it's crucial to discuss any concerns with your doctor. 4. Allergic reactions: Some people may experience allergic reactions to Humira, such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat. Seek immediate medical attention if you experience these symptoms. 5. Hepatitis B virus (HBV) reactivation: If you have a history of HBV infection, Humira may cause the virus to become active again. Your doctor will evaluate your HBV status before initiating treatment. 6. Neurological conditions: Rare cases of nervous system disorders, such as multiple sclerosis or optic neuritis, have been reported in patients using Humira. If you experience new or worsening symptoms, consult your healthcare provider. These are just some of the warnings associated with Humira use. It's crucial to discuss your medical history and any potential risks with your doctor before starting this medication, and to promptly report any concerning symptoms during treatment. Your healthcare provider will closely monitor your progress and ensure that the benefits outweigh the possible risks.
Before taking Humira, there are several important warnings to consider. Humira is a medication that contains adalimumab and is commonly prescribed for the treatment of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. Firstly, individuals who are considering Humira should inform their healthcare provider if they have an active infection, including tuberculosis or any other type of infection. Humira can weaken the immune system, making it harder for the body to fight off infections. It's crucial to receive appropriate treatment for any existing infections before starting Humira. Another important consideration is the risk of serious allergic reactions. Patients should disclose any history of allergic reactions to Humira or similar medications to their doctor. Signs of an allergic reaction may include difficulty breathing, swelling of the face, lips, tongue or throat, and hives. Furthermore, individuals with a history of certain medical conditions or diseases may require additional monitoring while using Humira. These conditions include, but are not limited to, multiple sclerosis, heart disease, liver disease, and blood disorders. Lastly, it is essential to discuss any potential risks and benefits of Humira during pregnancy or while breastfeeding with a healthcare provider. It is not recommended to start or continue Humira during pregnancy or breastfeeding without consulting a doctor. It is important to adhere to the prescribed dosage and follow all instructions provided by the healthcare provider. Patients should report any side effects or concerns to their doctor promptly. Following these precautions will help ensure the safe and effective use of Humira for the treatment of inflammatory conditions.
Humira, also known by its generic name adalimumab, is a medication used to treat various inflammatory conditions, including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and other autoimmune disorders. While Humira can be effective in managing these conditions, it is essential to be aware of potential side effects. Common side effects of Humira may include injection site reactions, such as redness, swelling, itching, or pain. Some individuals may also experience headaches, dizziness, or gastrointestinal symptoms, such as nausea, diarrhea, or abdominal pain. In some cases, Humira may lead to more severe side effects that require immediate medical attention. These might include severe allergic reactions, signs of infection (such as fever, chills, or persistent cough), unusual fatigue, persistent joint pain or swelling, or symptoms related to the nervous system, such as numbness, tingling, or vision changes. It is important to promptly report any concerning reactions to your healthcare provider. Additionally, Humira may increase the risk of developing certain infections, including tuberculosis and other opportunistic infections. Before starting Humira, your doctor will typically evaluate your medical history and perform tests to check for pre-existing infections. Regular monitoring during treatment is essential. It is crucial to remember that everyone may respond differently to medication, and not all individuals will experience the same side effects. If you have any concerns about the potential side effects of Humira, it is recommended to discuss them with your healthcare provider, who can provide personalized guidance based on your specific medical situation.
The active ingredient in Humira is adalimumab. Adalimumab is a monoclonal antibody that works by targeting and blocking a protein called tumor necrosis factor alpha (TNF-alpha). This protein is involved in the body's inflammatory response and plays a role in various autoimmune disorders. Additionally, the inactive ingredients in Humira include mannitol, citric acid monohydrate, sodium citrate dihydrate, sodium chloride, and polysorbate 80. These inactive ingredients help to stabilize and preserve the medication. It is worth noting that Humira is available in different formulations, including prefilled syringes and prefilled pens. However, the active ingredient and inactive ingredients remain the same across all formulations.
Humira, also known as adalimumab, is a medication that needs to be stored properly to maintain its effectiveness. Here are some guidelines for handling the storage of Humira: 1. Refrigeration: Humira should be stored in a refrigerator at a temperature between 36°F to 46°F (2°C to 8°C). Make sure the medication is kept in its original packaging and protected from light. Do not freeze Humira, as it can lose its efficacy. 2. Transportation: If you need to transport Humira, it can be kept at room temperature (up to 77°F or 25°C) for a maximum of 14 days. After this period, it should be discarded if not used. 3. Handling: Humira should be protected from excessive heat, moisture, and light. Do not shake the medication vigorously, as this can affect its composition. Inspect the medication visually before use, and do not use if it appears discolored or contains particles. 4. Avoid Exposure: Keep Humira away from children and pets. Store it in a secure place, out of reach from anyone who might accidentally ingest it. Also, do not expose the medication to extreme temperatures or direct sunlight. It's important to follow these storage guidelines to ensure the effectiveness and safety of Humira. If you have any specific concerns or questions about storage, it's always best to consult with your healthcare provider or pharmacist for personalized advice.